- ►prsjournal.com MV Emerson, AK Lauer, CJ Flaxel, DJ Wilson, PJ … - Retina, 2007 - pdfs.journals.lww.com Twenty eyes (25%) appeared to have a sustained response to a single injection and did not
require further injections through 3 months. Two patients had a potentially drug-related adverse
event (ischemic stroke and myocardial infarction). No serious injection-related adverse ... Cited by 88 - Related articles - BL Direct - All 4 versions
- ►prsjournal.com R Manzano, GA Peyman, P Khan, PE Carvounis, … - British Journal of …, 2007 - bjo.bmj.com Methods: Silver nitrate sticks (75% silver nitrate, 25% potassium nitrate) were used to perform
chemical cauterisation on the corneas of 16 eyes from 16 male Long Evans rats. For the following
7 days, the 10 eyes in the treatment group were instilled with bevacizumab 4 mg/ml drops ... Cited by 72 - Related articles - BL Direct - All 6 versions
L Wu, MA Martínez-Castellanos, H Quiroz-Mercado, … - Graefe's Archive for …, 2008 - Springer Abstract Background Vascular endothelial growth factor (VEGF) plays an important role in many
diseases of the posterior pole that are characterized by macular edema and/or intraocular
neovascularization. Recently anti-VEGF agents such as ranibizumab and pegaptanib ... Cited by 67 - Related articles - BL Direct - All 2 versions
- ►80.35.244.216 [PDF] ZF Bashshur, ZA Haddad, A Schakal, RF Jaafar, M … - American Journal of …, 2007 - Elsevier Sixty patients (60 eyes) with subfoveal choroidal neovascular membrane (CNV) attributable to
AMD participated in this study at the American University of Beirut and Hotel Dieu de France
Retina Clinics. All lesion types were included except for retinal angiomatous proliferation. ... Cited by 66 - Related articles - All 38 versions
- ►puntodeencuentro.biz [PDF] RD Jager, WF Mieler, JW Miller - New England Journal of Medicine, 2008 - content.nejm.org Age-related macular degeneration is the leading cause of irreversible blindness in people 50
years of age or older in the developed world. 1 , 2 More than 8 million Americans have age-related
macular degeneration, and the overall prevalence of advanced age-related macular ... Cited by 54 - Related articles - BL Direct - All 41 versions
SS Lynch, CM Cheng - Annals of Pharmacotherapy, 2007 - Harvey Whitney Books Low vision and blindness, respectively, affect an estimated 2.4 million Amer- icans and 937 000
of those over the age of 40 years. It is expected that 5.5 mil- lion Americans will be affected by
these conditions by the year 2020. Diseases of aging are the most common etiology of ... Cited by 49 - Related articles - BL Direct - All 4 versions
- ►prsjournal.com RB Bhisitkul - British Medical Journal, 2006 - bjo.bmj.com Decades of research on vascular endothelial growth factor (VEGF) have reached fruition with
the recent development of intravitreal anti-VEGF treatments for exudative age-related macular
degeneration. VEGF is a critical regulator of angiogenesis and vascular permeability with ... Cited by 47 - Related articles - BL Direct - All 6 versions
- ►prsjournal.com I Bahar, I Kaiserman, P McAllum, D Rootman, A … - Cornea, 2008 - journals.lww.com Results: No significant ocular or systemic adverse events were ob- served during 3.5 6 1.1 months
of follow-up. Seven patients showed partial regression of vessels. The extent decreased from
6.0 6 1.2 (SD) clock hours before the injection to 4.6 6 1.0 clock hours after bevacizumab ... Cited by 48 - Related articles - BL Direct - All 7 versions
S Peters, P Heiduschka, S Julien, F Ziemssen, H … - American Journal of …, 2007 - Elsevier Choriocapillaris endothelial cell fenestrations were significantly reduced after intravitreal injection
of bevacizumab. Fenestration was lowest on day four (15.9 ± 6.7 per 25 μm) and increased again
from days seven to 14, but was still significantly lower than in the control (66.2 ± 9.5 per ... Cited by 39 - Related articles - All 2 versions
